Clinical Trial Update: The REMIND Study- SPARK Neuro Software Study [NA]

View source ↗

Summary

The REMIND SPARK Neuro Software Study has completed, assessing Spark Neuro's software intervention for Alzheimer's disease and cognitive impairment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Snippet

Sponsor: Spark Neuro Inc. | Conditions: Alzheimer Disease, Cognitive Impairment | NA | Status: COMPLETED